Volume 56, Pages S71-S74 (November 1999)

Slides:



Advertisements
Similar presentations
Evaluation and treatment of coronary artery disease in patients with end-stage renal disease Peter A. McCullough Kidney International Volume 67, Pages.
Advertisements

Volume 64, Issue 4, Pages (October 2003)
Beta blockers in the management of chronic kidney disease
Anemia management in chronic kidney disease
Volume 56, Pages S95-S98 (November 1999)
Long-term follow-up of patients randomized to biocompatible or conventional peritoneal dialysis solutions show no difference in peritonitis or technique.
Volume 64, Pages S72-S77 (November 2003)
Regional citrate versus systemic heparin anticoagulation for continuous renal replacement in critically ill patients  Demetrios J. Kutsogiannis, R.T.Noel.
Continuous renal replacement therapy in the critically ill patient
Volume 80, Issue 10, Pages (November 2011)
Progression of renal failure and hypertensive nephrosclerosis
Volume 63, Pages S88-S90 (June 2003)
C-reactive protein and dialysis access
Regional citrate anticoagulation in continuous venovenous hemofiltration in critically ill patients with a high risk of bleeding  Runolfur Palsson, John.
Volume 70, Pages S21-S25 (December 2006)
George A. Kaysen, Burl R. Don
Volume 64, Issue 4, Pages (October 2003)
Abnormalities in lipoprotein metabolism in hemodialysis patients
A new era in phosphate binder therapy: What are the options?
D. Coyne  Kidney International  Volume 69, Pages S1-S3 (May 2006)
Nephrology Crosswords: Hemodialysis
The epidemiology of chronic kidney disease
Paricalcitol therapy for secondary hyperparathyroidism in patients on maintenance hemodialysis previously treated with calcitriol: A single-center crossover.
Edmund G. Lowrie  Kidney International 
Study of Heart and Renal Protection (SHARP)
Volume 73, Pages S5-S17 (April 2008)
Body size and outcomes on peritoneal dialysis in the United States
Blood pressure targets in hemodialysis patients
Volume 75, Issue 11, Pages (June 2009)
Endothelial dysfunction and inflammation: What is the link?
Volume 57, Issue 3, Pages (March 2000)
New insights in uremic toxins
The third World Kidney Day: Looking back and thinking forward
Effects of hemodialysis on cardiac function
Volume 64, Pages S72-S77 (November 2003)
Volume 69, Issue 12, Pages (June 2006)
Volume 69, Issue 3, Pages (February 2006)
Microbiology and outcomes of peritonitis in North America
Nephrology in Latin America, with special emphasis on Brazil
Alternate-day dialysis may be needed for hemodialysis patients
Juan M. Lopez-Gomez, Eduardo Verde, Rafael Perez-Garcia 
AGEs in foods: Do they play a role in uremia?
Simvastatin in nephrotic syndrome
Volume 82, Issue 9, Pages (November 2012)
Daily nocturnal home hemodialysis
Current status of maintenance hemodialysis in Beijing, China
Phosphate binders on iron basis: A new perspective?
Organ transplantation goes to the movies
Volume 70, Pages S84-S90 (November 2006)
Atherosclerotic nephropathy
Volume 55, Pages S3-S16 (June 1999)
Volume 56, Pages S84-S87 (November 1999)
Volume 80, Issue 10, Pages (November 2011)
Volume 64, Issue 5, Pages (November 2003)
Volume 56, Pages S37-S40 (November 1999)
Charles A. Herzog  Kidney International 
Is complement a target for therapy in renal disease?
Advisory about gadolinium calls for caution in the treatment of uremic patients with lanthanum carbonate  S. Aime, C. Canavese, P. Stratta  Kidney International 
Volume 70, Issue 5, Pages (September 2006)
The international realities of live donor kidney transplantation
Volume 70, Issue 10, Pages (November 2006)
The International Pediatric Peritonitis Registry: Starting to walk
Evaluation of the Losartan in Hemodialysis (ELHE) Study
Relationship between advanced glycoxidation end products, inflammatory markers/acute-phase reactants, and some autoantibodies in chronic hemodialysis.
Recombinant hirudin (lepirudin) as anticoagulant in intensive care patients treated with continuous hemodialysis  Karl-Georg Fischer, M.D., Andreas van.
Abby S. Kazley, Kit N. Simpson, Kenneth D. Chavin, Prabhakar Baliga 
Volume 55, Pages S41-S46 (June 1999)
E.F. Vonesh, J.J. Snyder, R.N. Foley, A.J. Collins 
Asymmetric dimethylarginine: A cardiovascular risk factor in renal disease?  Danilo Fliser, Jan T. Kielstein, Hermann Haller, Stefanie M. Bode-Böger  Kidney.
Stephen Pastan, J. Michael Soucie, William M. McClellan 
Presentation transcript:

Volume 56, Pages S71-S74 (November 1999) Continuous venovenous hemodialysis treatment in critically ill patients after liver transplantation  Peter Lütkes, Jens Lutz, Jan Loock, Anton Daul, Christoph Broelsch, Thomas Philipp, Dr Uwe Heemann  Kidney International  Volume 56, Pages S71-S74 (November 1999) DOI: 10.1046/j.1523-1755.56.s72.4.x Copyright © 1999 International Society of Nephrology Terms and Conditions

Figure 1 Bilirubin and aspartate aminotransferase (ASAT) levels in the continuous venovenous hemodialysis (▪; CVVH) and the control (▾) group in the first 14 days after transplantation. Kidney International 1999 56, S71-S74DOI: (10.1046/j.1523-1755.56.s72.4.x) Copyright © 1999 International Society of Nephrology Terms and Conditions

Feedback: Privacy Policy Feedback
Do Not Sell My Personal Information
About project: SlidePlayer Terms of Service

© 2025 SlidePlayer.com. Inc. All rights reserved.